Drebrin自身抗体在癫痫发作及疑似脑炎患者中的研究
该研究在4例病因未明的成人起病癫痫并疑似脑炎患者中鉴定出Drebrin作为自身抗体靶点,血清抗Drebrin抗体阳性患者表现为反复癫痫发作、记忆障碍及脑脊液蛋白升高,影像可见杏仁核海马T2信号增高和海马硬化,活检一例显示T淋巴细胞性脑炎。体外实验表明抗Drebrin抗体可致突触组成异常、Drebrin分布改变及神经元网络高兴奋性,提示该抗体定义了一种慢性综合征,应考虑免疫抑制治疗。
要点
- 抗Drebrin抗体见于成人起病癫痫疑似脑炎患者,表现为慢性反复发作和神经精神损害。
- 临床可见记忆障碍、脑脊液蛋白升高、杏仁核海马T2信号增高及海马硬化。
- 体外实验显示抗Drebrin抗体导致突触异常和神经元网络高兴奋性。
核心结论
- 抗Drebrin自身抗体定义了一种以反复癫痫发作和神经精神损害为特征的慢性综合征,伴边缘系统及偶见皮层炎症,应考虑免疫抑制治疗。
研究设计与样本
- 对4例成人起病癫痫且疑似脑炎、病因未明、自身抗体筛查结果相似的患者血清进行表位鉴定。
- 结合免疫印迹、免疫沉淀、质谱、原代神经元培养亚细胞结合模式分析及野生型和Drebrin敲除小鼠脑组织免疫组化。
- 体外分析抗体暴露对突触形成、形态及神经元兴奋性的影响。
主要发现
- 一例患者血清免疫印迹显示约70kDa强信号,质谱提示Drebrin为 putative 抗原。
- 另3例血清在Western blotting约70kDa处亦呈强免疫反应,均为抗Drebrin阳性。
- 抗Drebrin血清阳性患者出现癫痫发作、记忆障碍和脑脊液蛋白含量增高。
- 脑MRI改变包括杏仁核海马T2信号增高和海马硬化。
- 一例抗Drebrin血清阳性患者诊断性活检显示T淋巴细胞性脑炎。
临床怎么用
- 对成人起病反复癫痫发作且疑似脑炎、常规病因未明的患者,可考虑检测抗Drebrin抗体。
- 抗Drebrin抗体阳性者应评估记忆障碍、脑脊液蛋白及边缘系统MRI改变。
- 该病为慢性综合征,应考虑免疫抑制治疗。
局限性
- 研究仅基于4例患者,样本量小。
- 未报告抗体检测的敏感性、特异性或标准化阈值。
- 免疫抑制治疗的疗效未在该研究中评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Assess occurrence of the dendritic spine scaffolding protein Drebrin as a pathophysiologically relevant autoantibody target in patients with recurrent seizures and suspected encephalitis as leading symptoms. METHODS: Sera of 4 patients with adult onset epilepsy and suspected encephalitis of unresolved etiology and equivalent results in autoantibody screening were subjected to epitope identification. We combined a wide array of approaches, ranging from immunoblotting, immunoprecipitation, mass spectrometry, subcellular binding pattern analyses in primary neuronal cultures, and immunohistochemistry in brains of wild-type and Drebrin knockout mice to in vitro analyses of impaired synapse formation, morphology, and aberrant neuronal excitability by antibody exposure. RESULTS: In the serum of a patient with adult onset epilepsy and suspected encephalitis, a strong signal at ∼70kDa was detected by immunoblotting, for which mass spectrometry revealed Drebrin as the putative antigen. Three other patients whose sera also showed strong immunoreactivity around 70kDa on Western blotting were also anti-Drebrin-positive. Seizures, memory impairment, and increased protein content in cerebrospinal fluid occurred in anti-Drebrin-seropositive patients. Alterations in cerebral magnetic resonance imaging comprised amygdalohippocampal T2-signal increase and hippocampal sclerosis. Diagnostic biopsy revealed T-lymphocytic encephalitis in an anti-Drebrin-seropositive patient. Exposure of primary hippocampal neurons to anti-Drebrin autoantibodies resulted in aberrant synapse composition and Drebrin distribution as well as increased spike rates and the emergence of burst discharges reflecting network hyperexcitability. INTERPRETATION: Anti-Drebrin autoantibodies define a chronic syndrome of recurrent seizures and neuropsychiatric impairment as well as inflammation of limbic and occasionally cortical structures. Immunosuppressant therapies should be considered in this disorder. ANN NEUROL 2020;87:869-884.
引用
- Pitsch J, Kamalizade D, Braun A, et al. Drebrin Autoantibodies in Patients with Seizures and Suspected Encephalitis. Ann Neurol. 2020. PMID: 32196746. doi:10.1002/ana.25720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。